Efficacy and Safety of Ropeginterferon Alfa 2b (P1101) for Patients With Polycythemia Vera

NCT06290765 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Polycythemia Vera
Myeloproliferative Neoplasm

Interventions

DRUG: Ropeginterferon alfa-2b
PROCEDURE: Phlebotomy and aspirin

Sponsor

PharmaEssentia